Atomoxetine restores the response inhibition network in Parkinson's disease.
Saved in:
| Title: | Atomoxetine restores the response inhibition network in Parkinson's disease. |
|---|---|
| Authors: | Rae CL; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK., Nombela C; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Rodríguez PV; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Ye Z; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Hughes LE; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK., Jones PS; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Ham T; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Rittman T; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Coyle-Gilchrist I; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Regenthal R; 3 Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, 04107, Germany., Sahakian BJ; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 5 Department of Psychiatry, University of Cambridge, CB2 0SZ, Cambridge, UK., Barker RA; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK., Robbins TW; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 6 Department of Experimental Psychology, University of Cambridge, CB2 3EB, Cambridge, UK., Rowe JB; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK james.rowe@mrc-cbu.cam.ac.uk. |
| Source: | Brain : a journal of neurology [Brain] 2016 Aug; Vol. 139 (Pt 8), pp. 2235-48. Date of Electronic Publication: 2016 Jun 24. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27343257 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Atomoxetine restores the response inhibition network in Parkinson's disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rae+CL%22">Rae CL</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK.<br /><searchLink fieldCode="AU" term="%22Nombela+C%22">Nombela C</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Rodríguez+PV%22">Rodríguez PV</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Ye+Z%22">Ye Z</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Hughes+LE%22">Hughes LE</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK.<br /><searchLink fieldCode="AU" term="%22Jones+PS%22">Jones PS</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Ham+T%22">Ham T</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Rittman+T%22">Rittman T</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Coyle-Gilchrist+I%22">Coyle-Gilchrist I</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Regenthal+R%22">Regenthal R</searchLink>; 3 Division of Clinical Pharmacology, Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, 04107, Germany.<br /><searchLink fieldCode="AU" term="%22Sahakian+BJ%22">Sahakian BJ</searchLink>; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 5 Department of Psychiatry, University of Cambridge, CB2 0SZ, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Barker+RA%22">Barker RA</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK.<br /><searchLink fieldCode="AU" term="%22Robbins+TW%22">Robbins TW</searchLink>; 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK 6 Department of Experimental Psychology, University of Cambridge, CB2 3EB, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Rowe+JB%22">Rowe JB</searchLink>; 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0SZ, UK 2 Medical Research Council Cognition and Brain Sciences Unit, Cambridge, CB2 7EF, UK 4 Behavioural and Clinical Neuroscience Institute, Cambridge, CB2 3EB, UK james.rowe@mrc-cbu.cam.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372537%22">Brain : a journal of neurology</searchLink> [Brain] 2016 Aug; Vol. 139 (Pt 8), pp. 2235-48. <i>Date of Electronic Publication: </i>2016 Jun 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372537 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2156 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200068950%22">00068950 </searchLink><i>NLM ISO Abbreviation: </i>Brain <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27343257 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/brain/aww138 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2235 Titles: – TitleFull: Atomoxetine restores the response inhibition network in Parkinson's disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rae CL – PersonEntity: Name: NameFull: Nombela C – PersonEntity: Name: NameFull: Rodríguez PV – PersonEntity: Name: NameFull: Ye Z – PersonEntity: Name: NameFull: Hughes LE – PersonEntity: Name: NameFull: Jones PS – PersonEntity: Name: NameFull: Ham T – PersonEntity: Name: NameFull: Rittman T – PersonEntity: Name: NameFull: Coyle-Gilchrist I – PersonEntity: Name: NameFull: Regenthal R – PersonEntity: Name: NameFull: Sahakian BJ – PersonEntity: Name: NameFull: Barker RA – PersonEntity: Name: NameFull: Robbins TW – PersonEntity: Name: NameFull: Rowe JB IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2016 Aug Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1460-2156 Numbering: – Type: volume Value: 139 – Type: issue Value: Pt 8 Titles: – TitleFull: Brain : a journal of neurology Type: main |
| ResultId | 1 |